Previous studies have demonstrated that REM sleep suppression produced
by the serotonin, agonist eltoprazine (1 mg/kg b.i.d., administered i
.p.) is followed by a dramatic rebound in REM sleep. In the present st
udy, cats were treated with scopolamine (2 mg/kg b.i.d.) after 3 days
of eltoprazine-induced REM sleep suppression. During scopolamine treat
ment, the percentage of REM sleep (9.9 +/- 3.5%) was well below baseli
ne levels (13.7 +/- 1.6%; P < 0.05). Even after the 3-day scopolamine
treatment ended, the subsequent REM sleep rebound after the combined e
ltoprazine-scopolamine treatment (16.8 +/- 2.8%REM sleep during 3-day
rebound; P < 0.10 compared to baseline) was less than a third of the r
ebound normally seen after eltoprazine. These results provide evidence
for the reciprocal relationship between acetylcholine and serotonin a
nd suggest a new set-point model for the mechanism of REM sleep regula
tion and rebound.